Nervous System Disorders Of Monoclonal Igm

Mouse Anti Human Macrophage (Tissue And Proliferative Disorders) Monoclonal Antibody

DMABT-52185MH 0.5 ml
EUR 1226.4

Human IgG antibody Laboratories manufactures the nervous system disorders of monoclonal igm reagents distributed by Genprice. The Nervous System Disorders Of Monoclonal Igm reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm monoclonal. Other Nervous products are available in stock. Specificity: Nervous Category: System Group: Disorders Of

Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit

96T
EUR 559.2

human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit

96T
EUR 577.2

human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit

48T
EUR 398.4

Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit

96T
EUR 433.2

human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit

48T Ask for price

human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit

96T Ask for price

Mouse phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM

48T Ask for price

Disorders Of information

Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF594 conjugate, 0.1mg/mL

BNC943793-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF488A conjugate, 0.1mg/mL

BNC883792-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF488A conjugate, 0.1mg/mL

BNC883792-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF488A conjugate, 0.1mg/mL

BNC883793-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF488A conjugate, 0.1mg/mL

BNC883793-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), Biotin conjugate, 0.1mg/mL

BNCB3792-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), Biotin conjugate, 0.1mg/mL

BNCB3792-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), Biotin conjugate, 0.1mg/mL

BNCB3793-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), Biotin conjugate, 0.1mg/mL

BNCB3793-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF640R conjugate, 0.1mg/mL

BNC403792-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF640R conjugate, 0.1mg/mL

BNC403792-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF640R conjugate, 0.1mg/mL

BNC403793-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF640R conjugate, 0.1mg/mL

BNC403793-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF405S conjugate, 0.1mg/mL

BNC043792-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF405S conjugate, 0.1mg/mL

BNC043792-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF405S conjugate, 0.1mg/mL

BNC043793-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF405S conjugate, 0.1mg/mL

BNC043793-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application